NASDAQ:EPIX - ESSA Pharma Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$3.10 -0.04 (-1.27 %)
(As of 08/16/2018 04:00 PM ET)
Previous Close$3.14
Today's Range$3.05 - $3.10
52-Week Range$2.00 - $12.74
Volume1,200 shs
Average Volume12,575 shs
Market Capitalization$18.27 million
P/E Ratio-0.39
Dividend YieldN/A
ESSA Pharma logoESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel therapeutics for the treatment of prostate cancer. It is developing EPI-506 that is in Phase 1/2 clinical trials for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Receive EPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations


Debt-to-Equity Ratio0.35
Current Ratio5.29
Quick Ratio5.29


Trailing P/E Ratio-0.39
Forward P/E Ratio-0.93
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($3.09) per share
Price / Book-1.00


EPS (Most Recent Fiscal Year)($8.00)
Net Income$-4,720,000.00
Net MarginsN/A
Return on Equity-13,659.00%
Return on Assets-137.41%


Outstanding Shares5,780,000
Market Cap$18.27 million

ESSA Pharma (NASDAQ:EPIX) Frequently Asked Questions

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release their next quarterly earnings announcement on Monday, December, 10th 2018. View Earnings Estimates for ESSA Pharma.

What price target have analysts set for EPIX?

2 equities research analysts have issued 1 year price targets for ESSA Pharma's shares. Their predictions range from $0.70 to $0.70. On average, they anticipate ESSA Pharma's stock price to reach $0.70 in the next twelve months. This suggests that the stock has a possible downside of 77.4%. View Analyst Price Targets for ESSA Pharma.

What is the consensus analysts' recommendation for ESSA Pharma?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ESSA Pharma in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ESSA Pharma.

Who are some of ESSA Pharma's key competitors?

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the folowing people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 68)
  • Mr. David S. Wood, Chief Financial Officer (Age 61)
  • Mr. Peter A. Virsik, Exec. VP & COO (Age 47)
  • Dr. Raymond Andersen, CTO, Sec. & Director (Age 71)
  • Dr. Marianne D. Sadar, Chief Scientific Officer & Director (Age 57)

Has ESSA Pharma been receiving favorable news coverage?

Headlines about EPIX stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ESSA Pharma earned a coverage optimism score of 0.01 on Accern's scale. They also gave media coverage about the company an impact score of 46.88 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for ESSA Pharma.

Who are ESSA Pharma's major shareholders?

ESSA Pharma's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Omega Fund Management LLC (18.77%) and DRW Securities LLC (0.59%).

Which major investors are buying ESSA Pharma stock?

EPIX stock was purchased by a variety of institutional investors in the last quarter, including Omega Fund Management LLC and DRW Securities LLC.

How do I buy shares of ESSA Pharma?

Shares of EPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of EPIX stock can currently be purchased for approximately $3.10.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of $18.27 million. The company earns $-4,720,000.00 in net income (profit) each year or ($8.00) on an earnings per share basis. ESSA Pharma employs 15 workers across the globe.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The company can be reached via phone at 778-331-0962.

MarketBeat Community Rating for ESSA Pharma (NASDAQ EPIX)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  135 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  219
MarketBeat's community ratings are surveys of what our community members think about ESSA Pharma and other stocks. Vote "Outperform" if you believe EPIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EPIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/16/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.